Details of the Drug Reposition

General Information of This Drug (ID: DMTMVEW)

Drug Name
JCAR014   DMTMVEW
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Phase 1/2 [1]
------------------------------------------------------------------------------------
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Mediastinal large B-cell lymphoma DISAUA10 2A60.32 Phase 1 [2]
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 1 [2]
B-cell lymphoma DISIH1YQ 2A86 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800041075)
2 ClinicalTrials.gov (NCT02706405) JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma